News View all Uniphar Group News > As medicine access experts, we keep our finger on the pulse of a fast-moving environment. We have created this space as a touchstone through which you can keep up to date with the latest access activity and insights. UResource typeAll resource typesInsightsNewsTopicAll topicsExpanded Access ProgrammeOptimizing Commercial Launch for Orphan Drugs With Expanded Access ProgramsInsightsZogenix Launches Global Access Program for FINTEPLA® (Fenfluramine) Oral SolutionNewsThe Expanded Access Program (EAP) PlaybookInsightsBenefits, Challenges and Practicalities of Collecting Real-World Data During Expanded Access ProgramsInsightsThe Real Value of Mapping the Expanded Access Program (EAP) EcosystemInsights3 Key Steps to bring EAPs to a Global MarketInsightsEvaluating the Cost Impact of an Expanded Access ProgramInsightsSIFI and Durbin Announce the Opening of an Early Access Program for Akantior the Treatment of Acanthamoeba KeratitisNewsCross-Border Expanded Access Programs: Reducing Barriers to Treatment AccessInsights
Benefits, Challenges and Practicalities of Collecting Real-World Data During Expanded Access ProgramsInsights
SIFI and Durbin Announce the Opening of an Early Access Program for Akantior the Treatment of Acanthamoeba KeratitisNews